Cargando…

Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons

Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies show it has wide ranging effects to treat other diseases. Animal and retrospective human studies indicate that Metformin treatment is neuroprotective in Parkinson’s Disease (PD), although the neuroprotective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayliss, Jacqueline A., Lemus, Moyra B., Santos, Vanessa V., Deo, Minh, Davies, Jeffrey S., Kemp, Bruce E., Elsworth, John D., Andrews, Zane B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965122/ https://www.ncbi.nlm.nih.gov/pubmed/27467571 http://dx.doi.org/10.1371/journal.pone.0159381

Ejemplares similares

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
por: Pérez‐Taboada, Iara, et al.
Publicado: (2020)

Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin Receptor
por: Coppens, Jessica, et al.
Publicado: (2017)

Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation
por: Korchounov, Alexei, et al.
Publicado: (2010)

GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
por: Nikolaus, Susanne, et al.
Publicado: (2018)

Nigrostriatal dopamine pathway regulates auditory discrimination behavior
por: Chen, Allen P. F., et al.
Publicado: (2022)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Selective ablation of striatal striosomes produces the deregulation of dopamine nigrostriatal pathway
por: Shumilov, Kirill, et al.
Publicado: (2018)

Chemogenetic activation of nigrostriatal dopamine neurons in freely moving common marmosets
por: Mimura, Koki, et al.
Publicado: (2021)

Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat
por: Nikolaus, Susanne, et al.
Publicado: (2021)

Nigrostriatal dopamine modulates the striatal-amygdala pathway in auditory fear conditioning
por: Chen, Allen P. F., et al.
Publicado: (2023)

Increasing dopamine synthesis in nigrostriatal circuits increases phasic dopamine release and alters dorsal striatal connectivity: implications for schizophrenia
por: Srivastav, Sunil, et al.
Publicado: (2023)

Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease rats☆
por: Zhou, Qingwei, et al.
Publicado: (2012)

Inhibition of Nigrostriatal Dopamine Release by Striatal GABA(A) and GABA(B) Receptors
por: Lopes, Emanuel F., et al.
Publicado: (2019)

Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit
por: Tozzi, Alessandro, et al.
Publicado: (2021)

Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model
por: Wolff, Erin F, et al.
Publicado: (2011)

Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration
por: Fernandez-Parrilla, Manuel A., et al.
Publicado: (2021)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
por: Caminiti, Silvia Paola, et al.
Publicado: (2017)

Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson’s disease motor symptoms without neuronal degeneration in adult mice
por: Isingrini, Elsa, et al.
Publicado: (2017)

Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit
por: Zhang, Jiahui, et al.
Publicado: (2021)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways
por: Salvatore, Michael F., et al.
Publicado: (2012)

Testosterone Induces Molecular Changes in Dopamine Signaling Pathway Molecules in the Adolescent Male Rat Nigrostriatal Pathway
por: Purves-Tyson, Tertia D., et al.
Publicado: (2014)

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder
por: Cao, Ruihua, et al.
Publicado: (2020)

A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
por: Björklund, Anders, et al.
Publicado: (2022)

Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity
por: Stutz, Bernardo, et al.
Publicado: (2019)

Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson’s disease
por: Hernandez-Chan, Nancy G., et al.
Publicado: (2015)

Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter
por: Condon, Mark D., et al.
Publicado: (2019)

Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
por: Blanco-Lezcano, Lisette, et al.
Publicado: (2018)

ErbB4 Null Mice Display Altered Mesocorticolimbic and Nigrostriatal Dopamine Levels as well as Deficits in Cognitive and Motivational Behaviors
por: Skirzewski, Miguel, et al.
Publicado: (2020)

Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
por: El-Ghaiesh, Sabah H., et al.
Publicado: (2020)

Dopamine Increases a Value-Independent Gambling Propensity
por: Rigoli, Francesco, et al.
Publicado: (2016)

Aldehyde dehydrogenase 1–positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum
por: Sgobio, Carmelo, et al.
Publicado: (2017)

Asymmetric Interaction of Neuropeptidase Activities between Cortico-Limbic Structures, Plasma and Cardiovascular Function after Unilateral Dopamine Depletions of the Nigrostriatal System
por: Banegas, Inmaculada, et al.
Publicado: (2022)

Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson’s Disease as a Manifestation of Neurodegeneration and Neuroplasticity
por: Kolacheva, Anna, et al.
Publicado: (2022)

Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors
por: Myslivecek, Jaromir
Publicado: (2022)

GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration
por: Quintino, Luis, et al.
Publicado: (2018)

Cerebral dopamine neurotrophic factor–deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice
por: Lindahl, Maria, et al.
Publicado: (2019)

Transgenic supplementation of SIRT1 fails to alleviate acute loss of nigrostriatal dopamine neurons and gliosis in a mouse model of MPTP-induced parkinsonism
por: Kitao, Yasuko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kuheimi949guf9cjjae4qdqf55